Meijsing SH, Pufall MA, So AY, Bates DL, Chen L, Yamamoto KR
First, confirm the form: the literature you are referencing almost always concerns the copper complex, so the material and its Certificate of Analysis should state GHK-Cu explicitly, not just GHK
K., & Garg, S
Currently, many clinical practice guidelines, including the consensus guideline of the American Diabetes Association and the European Association for the Study of Diabetes, recommend glucagon-like peptide-1 receptor agonist (GLP-1RA) as the first-line injectable agent ahead of basal insulin for most patients with T2DM ( So far, two different products containing fixed-ratio combinations (FRCs) of basal insulin and GLP-1RA were approved by the US Food and Drug Administration and European Medicines Agency: IGlarLixi, which is a combo of insulin glargine and lixisenatide, and IDegLira, which is a combo of insulin degludec and liraglutide ( Based on these backgrounds, this study aimed to evaluate the overall effect of adding basal insulin on persisting GLP-1RA treatment
Pandey et al., A
For example, when we had a question that a staff member over the phone was unsure about, they got back to us via email the next day with an answer
